Denying the wolf access to sheep's clothing

Journal of Clinical Investigation

Volumn 112, Issue 3, 2003, Pages 319-321

  Heller, Theo ^a   Hoofnagle, Jay H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS DELTA ANTIGEN; VIRUS RNA; VIRUS ANTIGEN;

HEPATITIS DELTA VIRUS; NONHUMAN; PRENYLATION; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; VIRUS ASSEMBLY; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; DELTA AGENT HEPATITIS; DISEASE MODEL; DRUG EFFECT; HUMAN; METABOLISM; MOUSE; NOTE; PATHOGENICITY; PHYSIOLOGY; PROTEIN PROCESSING; RNA EDITING; VIREMIA; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; DISEASE MODELS, ANIMAL; HEPATITIS D; HEPATITIS DELTA ANTIGENS; HEPATITIS DELTA VIRUS; HUMANS; MICE; PROTEIN ISOPRENYLATION; RNA EDITING; VIREMIA; VIRUS REPLICATION;

EID: 0041886853     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319417     Document Type: Review

References (14)

1. Rizzetto, M., et al. 1983. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann. Intern. Med. 98:437-441.
2. Hadziyannis, S.J. 1991. Use of alpha-interferon in the treatment of chronic delta hepatitis. J. Hepatol. 13(Suppl. 1):S21-S26.
3. Wang, K.S., et al. 1986. Structure, sequence and expression of the hepatitis delta (δ) viral genome. Nature. 323:508-514.
4. Branch, A.D., and Robertson, H.D. 1984. A replication cycle for viroids and other small infectious RNA's. Science. 223:450-455.
5. Rizzetto, M., et al. 1980. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J. Infect. Dis. 141:590-602.
6. Gaeta, G.B., Stornaiuolo, G., and Precone, D.F. 2001. Type B and D viral hepatitis: epidemiological changes in Southern Europe. Forum (Genova). 11:126-133.
7. He, L.F., et al. 1993. The size of the hepatitis delta agent. J. Med. Virol. 27:31-33.
8. Ryu, W.S., Netter, H.J., Bayer, M., and Taylor, J. 1993. Ribonucleoprotein complexes of hepatitis delta virus. J. Virol. 67:3281-3287.
9. Sharmeen, L., Kuo, M.Y., Dinter-Gottlieb, G., and Taylor, J. 1988. Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J. Virol. 62:2674-2679.
10. Casey, J.L., Bergmann, K.F., Brown, T.L., and Gerin, J.L. 1992. Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. Proc. Natl. Acad. Sci. U. S. A. 89:7149-7153.
11. Glenn, J.S., Watson, J.A., Havel, C.M., and White, J.M. 1992. Identification of a prenylation site in delta virus large antigen. Science. 256:1331-1333.
12. Bordier, B.B., et al. 2003. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J. Clin. Invest. 112:407-414. doi:10.1172/JCI200317704.
13. Schafer, W.R., and Rine, J. 1992. Protein prenylation: genes, enzymes, targets, and functions. Annu. Rev. Genet. 26:209-237.
14. Lau, D.T., et al. 1999. Lamivudine for chronic delta hepatitis. Hepatology. 30:546-549.